Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review

Atrial fibrillation as an independent risk factor for stroke: the Framingham study

Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388

Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation

Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society

Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805

Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation

Hart, R. G., Benavente, O., McBride, R., & Pearce, L. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00003 · Cited by 1,636

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary

Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,362

A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community

Wang, T. J., Massaro, J. M., Levy, D. A., Vasan, R. S., Wolf, P. A., D’Agostino, R. B., Larson, M. G., Kannel, W. B., & Benjamin, E. J. (2003) · JAMA · doi:10.1001/jama.290.8.1049 · Cited by 790

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · EP Europace · doi:10.1093/europace/eul097 · Cited by 670

Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy

Hart, R. G., Pearce, L. A., Rothbart, R. M., McAnulty, J. H., ASINGER, R. W., & Halperin, J. L. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00489-1 · Cited by 662

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary

Authors Task Force Members, Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl176 · Cited by 646

Antithrombotic Therapy in Atrial Fibrillation

Singer, D. E., Albers, G. W., Dalen, J. E., Go, A. S., Halperin, J. L., & Manning, W. J. (2004) · CHEST Journal · doi:10.1378/chest.126.3_suppl.429s · Cited by 547

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403

Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes

Reeves, M. J., Bushnell, C. D., Howard, G., Gargano, J. W., Duncan, P. W., Lynch, G., Khatiwoda, A., & Lisabeth, L. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70193-5 · Cited by 1,362

Pathophysiological mechanisms of atrial fibrillation: a translational appraisal

Schotten, U., Verheule, S., Kirchhof, P., & Goette, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00031.2009 · Cited by 1,273

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.024 · Cited by 1,077

Antithrombotic Therapy for Atrial Fibrillation

Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R. A., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M. P., Werring, D. J., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.07.040 · Cited by 963

Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

Ogilvie, I. M., Newton, N., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.11.025 · Cited by 929

Antithrombotic Therapy for Atrial Fibrillation

You, J. J., Singer, D. E., Howard, P. A., Lane, D. A., Eckman, M. H., Fang, M. C., Hylek, E. M., Schulman, S., Go, A. S., Hughes, M., et al. (2012) · CHEST Journal · doi:10.1378/chest.11-2304 · Cited by 933

Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data

Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0508 · Cited by 371

Atrial fibrillation

Lip, G. Y. H., Tse, H., & Lane, D. A. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61514-6 · Cited by 347

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

Huber, K., Andreotti, F., Arnesen, H., Airaksinen, J. K. E., Cuisset, T., Kirchhof, P. F., Marín, F. R., & Lip, G. Y. H. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-08-0580 · Cited by 304

Bleeding risk assessment and management in atrial fibrillation patients

Fauchier, L., Hylek, E. M., Knight, E., Lane, D. A., Levi, M. M., Marín, F. R., Palareti, G., Jp, C., Rubboli, A., Poli, D., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-10-0690 · Cited by 283

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options—a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

Kirchhof, P. F., Lip, G. Y. H., Gelder, I. C. V., Bax, J. J., Hylek, E. M., Kääb, S., Schotten, U., Wegscheider, K., Boriani, G., Brandes, A., et al. (2011) · EP Europace · doi:10.1093/europace/eur241 · Cited by 247

Untitled work

Goodman (2014) · doi:10.1016/j.jacc.2013.11.013 · Cited by 228

Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients

Cosmi, B., & Palareti, G. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-11-0730 · Cited by 224

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

Lip, G. Y. H., Andreotti, F., Fauchier, L., Huber, K., Hylek, E. M., Knight, E., Lane, D. A., Levi, M. M., Marín, F. R., Palareti, G., et al. (2011) · EP Europace · doi:10.1093/europace/eur126 · Cited by 224

Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

Lip, G. Y. H., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., Oto, A., Potpara, T., Steffel, J., Marín, F. R., et al. (2017) · EP Europace · doi:10.1093/europace/eux091 · Cited by 233

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial

Lópes, R. D., Al‐Khatib, S. M., Wallentin, L. C., Yang, H., Ansell, J., Bahit, M. C., Caterina, R. D., Dorian, P., Easton, J. D., Erol, Ç., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60986-6 · Cited by 210

Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

Olesen, J. B., Lip, G. Y. H., Hansen, P. R., Lindhardsen, J., Ahlehoff, O., Andersson, C., Weeke, P. E., Hansen, M. L., Gislason, G., & Torp-Pedersen, C. T. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04378.x · Cited by 201

Diretriz Brasileira de Valvopatias - SBC 2011/ I Diretriz Interamericana de Valvopatias - SIAC 2011

Tarasoutchi, F., Montera, M. W., Grinberg, M., Barbosa, M., Piñeiro, D. E., Sánchez, C., & Barbosa, M. (2011) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2011002000001 · Cited by 192

Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy

Roldán, V., Marín, F. R., Fernández, H., Manzano‐Fernández, S., Gallego, P., Valdés, M., Vicente, V., & Lip, G. Y. H. (2012) · CHEST Journal · doi:10.1378/chest.12-0608 · Cited by 193

The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation

Roldán, V., Marín, F. R., Manzano‐Fernández, S., Gallego, P., Vilchez, J. A., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1623 · Cited by 190

Revised A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey

Pisters, R., Lane, D. A., Nieuwlaat, R., Crijns, H., & Lip, G. Y. H. (2012) · Cited by 171

Stroke and Thromboembolism in Atrial Fibrillation

Pisters, R., Lane, D. A., Marín, F. R., Camm, A. J., & Lip, G. Y. H. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-1036 · Cited by 162

Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation

Gallego, P., Roldán, V., Diaz, J. M. T., Gálvez, J., Valdés, M., Vicente, V., Marín, F. R., & Lip, G. Y. H. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.967000 · Cited by 149

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?

ZIMETBAUM, P. J., Thosani, A. J., Yu, H.-T., Xiong, Y., Lin, J., Kothawala, P., & Emons, M. F. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.11.015 · Cited by 147

Plasma von Willebrand Factor Levels Are an Independent Risk Factor for Adverse Events Including Mortality and Major Bleeding in Anticoagulated Atrial Fibrillation Patients

Roldán, V., Marín, F. R., Muiña, B., Diaz, J. M. T., Hernández‐Romero, D., Valdés, M., Vicente, V., & Lip, G. Y. H. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.033 · Cited by 131

A review on sex differences in stroke treatment and outcome

Appelros, P., Stegmayr, B. G., & Terént, A. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01258.x · Cited by 126

Initial Experience With a Novel Percutaneous Left Atrial Appendage Exclusion Device in Patients With Atrial Fibrillation, Increased Stroke Risk, and Contraindications to Anticoagulation

Massumi, A., Chelu, M. G., Nazeri, A., May, S., Afshar-Kharaghan, H., Saeed, M., Razavi, M., & Rasekh, A. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.11.061 · Cited by 121

Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'

Kirchhof, P. F., Bax, J. J., Blomstrom-Lundquist, C., Calkins, H., Camm, A. J., Cappato, R., Cosío, F. G., Crijns, H. J. G. M., Diener, H., Goette, A., et al. (2009) · EP Europace · doi:10.1093/europace/eup124 · Cited by 112

Gender in atrial fibrillation: Ten years later

Michelena, H. I., Powell, B. D., Brady, P. A., Friedman, P. A., & Ezekowitz, M. D. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.06.001 · Cited by 109

Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment

Antonucci, E., Grifoni, E., Abbate, R., Gensini, G. F., Prisco, D., & Poli, D. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-10-0635 · Cited by 95

Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management

Gumprecht, J. J., Domek, M., Lip, G. Y. H., & Shantsila, A. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0279-7 · Cited by 98

Stroke in atrial fibrillation: epidemiology and thromboprophylaxis

Lip, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04302.x · Cited by 91

Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options

Lip, G. Y. H., Gelder, I. C. V., Bax, J. J., Hylek, E. M., Kääb, S., Schotten, U., Wegscheider, K., Boriani, G., Ezekowitz, M. D., Diener, H. C., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-07-0517 · Cited by 91

Risk of Recurrent Stroke, Other Vascular Events and Dementia after Transient Ischaemic Attack and Stroke

Pendlebury, S. T., & Rothwell, P. M. (2009) · Cerebrovascular Diseases · doi:10.1159/000209260 · Cited by 91

Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study

Overvad, T. F., Skjøth, F., Lip, G. Y. H., Lane, D. A., Albertsen, I. E., Rasmussen, L. H., & Larsen, T. B. (2015) · Stroke · doi:10.1161/strokeaha.115.009371 · Cited by 87

Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis

Dawwas, G. K., Brown, J., Dietrich, E., & Park, H. (2019) · The Lancet Haematology · doi:10.1016/s2352-3026(18)30191-1 · Cited by 84

Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation

Stone, D. L., Byrne, T., & Pershad, A. (2013) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25065 · Cited by 80

Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation

Guo, Y., Apostolakis, S. Z., Blann, A. D., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., Wang, Y., & Lip, G. Y. H. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.052 · Cited by 80

Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method

Basger, B., Chen, T., & Moles, R. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001431 · Cited by 81

Risk stratification schemes, anticoagulation use and outcomes: the risk–treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation

Sandhu, R. K., Bakal, J. A., Ezekowitz, J. A., & McAlister, F. A. (2011) · Heart · doi:10.1136/heartjnl-2011-300901 · Cited by 79

Assessing the Risk of Bleeding in Patients With Atrial Fibrillation

Lip, G. Y. H., Banerjee, A., Lagrenade, I., Lane, D. A., Taillandier, S., & Fauchier, L. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.972869 · Cited by 78

Left Atrial Appendage Occlusion/Exclusion: Procedural Image Guidance with Transesophageal Echocardiography

Vainrib, A., Harb, S. C., Jaber, W. A., Benenstein, R., Aizer, A., Chinitz, L. A., & Sarić, M. (2017) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.09.014 · Cited by 76

Sex Differences in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism

Blanco-Molina, Á., Enea, I., Gadelha, T., Tufano, A., Bura-Rivière, A., Micco, P. D., Bounameaux, H., González, J., Villalta, J., & Monréal, M. (2014) · Medicine · doi:10.1097/md.0000000000000114 · Cited by 74

Edoxaban population pharmacokinetics and exposure–response analysis in patients with non-valvular atrial fibrillation

Yin, O. Q. P., Kimura, T., & Miller, R. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1736-4 · Cited by 71

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Houston, D. S., & Zarychanski, R. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0909962 · Cited by 68

Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans

Roughead, E. E., Barratt, J. D., Ramsay, E. N., Pratt, N. L., Ryan, P., Peck, R., Killer, G. T., & Gilbert, A. L. (2010) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2009.01149.x · Cited by 67

CHADS 2 , CHA 2 DS 2 -VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention

Puurunen, M. K., Kiviniemi, T., Schlitt, A., Rubboli, A., Dietrich, B., Karjalainen, P. P., Nyman, K., Niemelä, M. J., Lip, G. Y. H., & Airaksinen, J. K. E. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.01.007 · Cited by 67

Impact of Gender on the Prognosis of Patients With Nonvalvular Atrial Fibrillation

Inoue, H., Atarashi, H., Okumura, K., Yamashita, T., Origasa, H., Kumagai, N., Sakurai, M., Kawamura, Y., Kubota, I., Matsumoto, K., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.11.057 · Cited by 61

Clinical Implications of Leaks Following Left Atrial Appendage Ligation With the LARIAT Device

Gianni, C., Biase, L. D., Trivedi, C. G., Mohanty, S., Gökoğlan, Y., Günes, M. F., Bai, R., Al‐Ahmad, A., Burkhardt, J. D., Horton, R., et al. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2016.01.038 · Cited by 56

Ischaemic stroke and bleeding rates in ‘real-world’ atrial fibrillation patients

Ogilvie, I. M., Cowell, W., Lip, G. Y. H., & Welner, S. A. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-10-0674 · Cited by 54

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants

Ng, K. H., Hart, R. G., & Eikelboom, J. W. (2013) · Cardiology and Therapy · doi:10.1007/s40119-013-0019-y · Cited by 49

Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial

Vinereanu, D., Stevens, S. R., Alexander, J. H., Al‐Khatib, S. M., Avezum, Á., Bahit, M. C., Granger, C. B., Lópes, R. D., Halvorsen, S., Hanna, M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv447 · Cited by 51

Influence of sex on risk of bleeding in anticoagulated patients: a systematic review and meta‐analysis

Lapner, S. T., Cohen, N., & Kearon, C. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12529 · Cited by 47

Valor predictivo de la escala CHA2DS2-VASc en pacientes con fibrilación auricular de alto riesgo embólico en tratamiento anticoagulante

Jover, E., Roldán, V., Gallego, P., Hernández‐Romero, D., Valdés, M., Vicente, V., Lip, G. Y. H., & Marín, F. R. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.02.017 · Cited by 46

Use of Oral Anticoagulation among Stroke Patients with Atrial Fibrillation in China: The ChinaQUEST (Quality Evaluation of Stroke Care and Treatment) Registry Study

Gao, Q., Fu, X., Wei, J. W., Chen, X., Huang, Y., Wang, J., Anderson, C. S., Wong, K. S., & for the China QUEST Study Investigators (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00716.x · Cited by 44

Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation

Guo, Y., Wang, H., Tian, Y., Wang, Y., & Lip, G. Y. H. (2014) · CHEST Journal · doi:10.1378/chest.14-2018 · Cited by 43

Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: The Chin-Shan Community Cohort Study

Lip, G. Y. H., Lin, H., Hsu, H., Su, T., Chen, M.-F., Lee, Y., & Chien, K. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.076 · Cited by 43

Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: Would the novel oral anticoagulants have an impact?

Guo, Y., Pisters, R., Apostolakis, S. Z., Blann, A. D., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., Wang, Y., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.187 · Cited by 39

Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study

Okumura, K., Lip, G. Y. H., Akao, M., Tanizawa, K., Fukuzawa, M., Abe, K., Akishita, M., & Yamashita, T. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.08.017 · Cited by 38

Gender differences of bleeding and stroke risk in very Old atrial fibrillation patients on VKA treatment

Poli, D., Antonucci, E., Testa, S., Ageno, W., & Palareti, G. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.10.009 · Cited by 37

Predictive Value of the CHA2DS2-VASc Score in Atrial Fibrillation Patients at High Risk for Stroke Despite Oral Anticoagulation

Jover, E., Roldán, V., Gallego, P., Hernández‐Romero, D., Valdés, M., Vicente, V., Lip, G. Y. H., & Marín, F. R. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.02.016 · Cited by 36

Can We Predict Stroke in Atrial Fibrillation?

Lip, G. Y. H. (2012) · Clinical Cardiology · doi:10.1002/clc.20969 · Cited by 35

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

García-Fernández, A., Roldán, V., Rivera‐Caravaca, J. M., Hernández‐Romero, D., Valdés, M., Vicente, V., Lip, G. Y. H., & Marín, F. R. (2017) · Scientific Reports · doi:10.1038/srep41565 · Cited by 35

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies

Ding, W. Y., Harrison, S. L., Gupta, D., Lip, G. Y. H., & Lane, D. A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00054 · Cited by 36

Prevention of stroke in patients with atrial fibrillation: current strategies and future directions

Hohnloser, S. H., Duray, G. Z., Baber, U., & Halperin, J. L. (2008) · European Heart Journal Supplements · doi:10.1093/eurheartj/sun029 · Cited by 34

Characterization of the Proportion of Untreated and Antiplatelet Therapy Treated Patients With Atrial Fibrillation

Ogilvie, I. M., Welner, S. A., Cowell, W., & Lip, G. Y. H. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.02.353 · Cited by 32

Comparison of Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation

Aakre, C. A., McLeod, C. J., Cha, S. S., Tsang, T. S. M., Lip, G. Y. H., & Gersh, B. J. (2013) · Stroke · doi:10.1161/strokeaha.113.002585 · Cited by 32

Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review

Lane, D. A., Raichand, S., Moore, D., Connock, M. J., Fry-Smith, A., & Fitzmaurice, D. (2013) · Health Technology Assessment · doi:10.3310/hta17300 · Cited by 31

The Unrecognized Psychosocial Factors Contributing to Bleeding Risk in Warfarin Therapy

Diug, B. O., Evans, S., Lowthian, J. A., Maxwell, E. L., Dooley, M. J., Street, A., Wolfe, R. S., Cameron, P. A., & McNeil, J. J. (2011) · Stroke · doi:10.1161/strokeaha.111.615674 · Cited by 31

Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary

Lip, G. Y. H. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12140 · Cited by 29

Is the HAS-BLED score useful in predicting post-extraction bleeding in patients taking warfarin? A retrospective cohort study

Kataoka, T., Hoshi, K., & Ando, T. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010471 · Cited by 29

Anticoagulation in Heart Failure: a Review.

Zeitler, E. P., & Eapen, Z. J. (2015) · Europe PMC (PubMed Central) · doi:10.4022/jafib.1250 · Cited by 28

Elevated International Normalized Ratio after concurrent ingestion of cranberry sauce and warfarin

Mergenhagen, K. A., & Sherman, O. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080135 · Cited by 26

Peri-operative management of ophthalmic patients taking antithrombotic therapy

Lip, G. Y. H., Durrani, O. M., Roldán, V., Lip, P. L., Marín, F. R., & Reuser, T. Q. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02538.x · Cited by 25

Cardioembolic Stroke in Atrial Fibrillation-Rationale for Preventive Closure of the Left Atrial Appendage

Leithäuser, B., & Park, J. (2009) · Korean Circulation Journal · doi:10.4070/kcj.2009.39.11.443 · Cited by 27

Bleeding Complications Associated with Warfarin Treatment in Ischemic Stroke Patients with Atrial Fibrillation: A Population-Based Cohort Study

Seet, R. C. S., Rabinstein, A. A., Christianson, T. J. H., Petty, G. W., & Brown, R. D. (2013) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2013.01.019 · Cited by 21

Risk of bleeding and antibiotic use in patients receiving continuous phenprocoumon therapy

Ihle, P., Harder, S., Schübert, I., & Abbas, S. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-09-0723 · Cited by 21

Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care

Kirchhof, P. F., Pecen, L., Bakhai, A., de Asmundis, C., de Groot, J. R., Deharo, J., Kelly, P. J., Lévy, P., de Sá, E. L., Monteiro, P. F., et al. (2022) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvac042 · Cited by 21

Resuming anticoagulant therapy after intracerebral bleeding

Becattini, C., Sembolini, A., & Paciaroni, M. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.05.012 · Cited by 22

Management of warfarin-related intracerebral hemorrhage

Freeman, W. D., & Aguilar, M. I. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.2.271 · Cited by 19

Factors associated with warfarin discontinuation, including bleeding patterns, in atrial fibrillation patients

Suh, D., Choi, J. C., Schein, J. R., Kim, S., & Nelson, W. W. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.795142 · Cited by 18

Gender Differences in Anticoagulation and Antithrombotic Therapy

Rauch, U. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-30726-3_23 · Cited by 18

The Balance Between Stroke Prevention and Bleeding Risk in Atrial Fibrillation

Lip, G. Y. H. (2008) · Stroke · doi:10.1161/strokeaha.107.506832 · Cited by 17

The HAS-BLED Score is Associated With Major Bleeding in Patients After Cardiac Surgery

Santise, G., Nardella, S., Migliano, F., Testa, A., & Maselli, D. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.01.021 · Cited by 16

Risk factors for elevated INR values during warfarin therapy in hospitalized pediatric patients

Moffett, B. S., Ung, M., & Bomgaars, L. R. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23308 · Cited by 16

The Role of Multimodality Imaging in Percutaneous Left Atrial Appendage Suture Ligation with the LARIAT Device

Laura, D. M., Chinitz, L. A., Aizer, A., Holmes, D., Benenstein, R., Freedberg, R. S., Kim, E. E., & Sarić, M. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.04.014 · Cited by 15

Safety of anticoagulation in patients with atrial fibrillation and MDS / AML complicated by thrombocytopenia: An unresolved challenge: Can they be managed? A report of three cases and literature review

Caro, J., & Navada, S. C. (2018) · American Journal of Hematology · doi:10.1002/ajh.25045 · Cited by 15

Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario

Saksena, D. S., Mishra, Y. K., Muralidharan, S., Kanhere, V. M., Srivastava, P. K., & Srivastava, C. P. (2019) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-019-00789-z · Cited by 16

Stroke prevention with oral anticoagulation in older people with atrial fibrillation - a pragmatic approach.

Ali, A., Bailey, C., & Abdelhafiz, A. H. (2012) · Europe PMC (PubMed Central) · Cited by 15

Comparing Management and Outcomes in Men and Women With Nonvalvular Atrial Fibrillation

Arnson, Y., Hoshen, M., Senderey, A. B., Reges, O., Balicer, R. D., Leibowitz, M., Tsadok, M. A., & Haim, M. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.01.014 · Cited by 15

Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry)

Vemulapalli, S., Inohara, T., Kim, S., Thomas, L. E., Piccini, J. P., Patel, M. R., Chang, P., Fonarow, G. C., Ezekowitz, M. D., Hylek, E. M., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.02.010 · Cited by 15

β-Trace Protein and Prognosis in Patients With Atrial Fibrillation Receiving Anticoagulation Treatment

Vilchez, J. A., Roldán, V., Manzano‐Fernández, S., Fernández, H., Avilés-Plaza, F. V., Martínez-Hernández, P., Vicente, V., Valdés, M., Marín, F. R., & Lip, G. Y. H. (2013) · CHEST Journal · doi:10.1378/chest.13-0922 · Cited by 14

Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance

Salameh, P., Helou, E., Al-Hajje, Ajrouche, R., Awada, Rachidi, & Zein (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s41144 · Cited by 14

Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis

Zhu, W., Guo, L., Liu, F., Wan, R., Shen, Y., Lip, G. Y. H., & Hong, K. (2017) · Oncotarget · doi:10.18632/oncotarget.20870 · Cited by 14

Drugs in phase I and II clinical development for the prevention of stroke in patients with atrial fibrillation

Bentley, R., Hardy, L., Scott, L. J., Sharma, P., Philippou, H., & Lip, G. Y. H. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1897786 · Cited by 13

Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial

DiNicolantonio, J. J. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.671809 · Cited by 12

RISK OF BLEEDING IN ATRIAL FIBRILLATION PATIENTS TAKING ANTICOAGULANTS

Hussain, M., Krishna, L. S. R., Naaz, M., Siddiqui, R., Fatima, H., & Koneru, A. (2021) · Journal of Cardiovascular Disease Research

Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study

Dimarco, J., Flaker, G. C., Waldo, A. L., Corley, S. D., Greene, H. L., Safford, R. E., Rosenfeld, L. E., Mitrani, G., & Nemeth, M. A. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.11.015 · Cited by 217

Anticoagulation: risks and benefits in atrial fibrillation.

Fiore, L. D. (1996) · PubMed · Cited by 3

Stroke and Bleeding Risks in Patients with Atrial Fibrillation

Maan, A., Ruskin, J. N., & Heist, E. K. (2014) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2013.11.001

Anticoagulant-Related Bleeding in Older Persons With Atrial Fibrillation

Man‐Son‐Hing, M., & Laupacis, A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.13.1580 · Cited by 194